Osborne Clarke advises Tech Vision Fonds, Segulah Medical Acceleration, XGEN Venture and Gehrenberg on Series B financing round of Protembis
Osborne Clarke has advised the investors Tech Vision Fonds, Segulah Medical Acceleration, XGEN Venture and Gehrenberg on their (renewed) investment...
Published on
09/04/2024
Read time
1m